ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0166

Limitations in Activities of Daily Living Among Individuals with SLE

Laura Plantinga1, Jinoos Yazdany2, Courtney Hoge3, Charmayne M. Dunlop-Thomas4 and Patti Katz5, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Emory University, Atlanta, GA, 4Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 5UCSF, San Rafael, CA

Meeting: ACR Convergence 2024

Keywords: Aging, Disability, Epidemiology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: A better understanding of the capacity of individuals with SLE to perform routine daily life tasks is needed to effectively support the independence and quality of life of this rapidly aging population. To begin to address this gap, we aimed to estimate the burden of, and identify potential correlates of, limitations in activities of daily living (ADLs) among a population-based, primarily Black U.S. cohort of individuals with SLE.

Methods: Participants with validated SLE were recruited from an ongoing population-based cohort [Georgians Organized Against Lupus (GOAL)] for a single study visit (10/2019-5/2022), during which they reported their ability to independently perform various instrumental ADLs (IADLs) and basic ADLs (BADLs). Limitations were defined as having at least some difficulty performing at least one of the IADLs or BADLs. Descriptive statistics were calculated and age-, sex-, and race-adjusted associations [adjusted odds ratios (aORs)] of various participant characteristics with IADL and BADL limitations were assessed with logistic regression.

Results: Participants (N=447; mean age, 46 years; 92% female and 83% Black) commonly reported limitations in ADLs. More than half of participants (56%) reported IADL limitations, including limitations in housekeeping (51%), laundry (37%), and shopping (33%) (Figure 1); 44% reported limitations in independently performing BADLs, including transferring (27%), bathing (25%), dressing (24%), and continence (22%) (Figure 2). Higher disease activity (> vs. < median) was strongly associated with limitations in IADLs and BADLs (6.5-fold and 7.4-fold higher odds, respectively); higher scores for depression and perceived stress, lower educational attainment and income, and older age were also associated with ADL limitations (Figure 3).

Conclusion: Limitations in both IADLs and BADLs may be common in SLE, with prevalence estimates higher than those reported among older adults and those with several chronic diseases (including cardiovascular disease, chronic obstructive pulmonary, and cancer). Additionally, these limitations may be more likely among those who report more disease activity, depressive symptoms, and perceived stress and those who are older. Research to explore evidence-based strategies to prevent, mitigate, and support these limitations in the SLE population — thereby maximizing patients’ independence as they age — is warranted.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: L. Plantinga: None; J. Yazdany: AstraZeneca, 2, Aurinia, 5, Bristol-Myers Squibb(BMS), 2, UCB, 2; C. Hoge: None; C. Dunlop-Thomas: None; P. Katz: None.

To cite this abstract in AMA style:

Plantinga L, Yazdany J, Hoge C, Dunlop-Thomas C, Katz P. Limitations in Activities of Daily Living Among Individuals with SLE [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/limitations-in-activities-of-daily-living-among-individuals-with-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/limitations-in-activities-of-daily-living-among-individuals-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology